Glioma Inhibition by HGF/NK2, an Antagonist of Scatter Factor/Hepatocyte Growth Factor

This publication has 41 references indexed in Scilit:

• Disassociation of Met-Mediated Biological Responses In Vivo: the Natural Hepatocyte Growth Factor/Scatter Factor Splice Variant NK2 Antagonizes Growth but Facilitates Metastasis
  Molecular and Cellular Biology, 2000
• Reversion of Human Glioblastoma Malignancy by U1 Small Nuclear RNA/Ribozyme Targeting of Scatter Factor/Hepatocyte Growth Factor and c-met Expression
  JNCI Journal of the National Cancer Institute, 1999
• Gene therapy strategies for tumor antiangiogenesis
  JNCI Journal of the National Cancer Institute, 1998
• Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells
  International Journal of Cancer, 1998
• Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli
  Biochemical Journal, 1997
• Scatter Factor/Hepatocyte Growth Factor Expression Enhances Human Glioblastoma Tumorigenicity and Growth
  Biochemical and Biophysical Research Communications, 1997
• Scatter factor expression and regulation in human glial tumors
  International Journal of Cancer, 1996
• A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis.
  Proceedings of the National Academy of Sciences, 1992
• Identification of a Competitive HGF Antagonist Encoded by an Alternative Transcript
  Science, 1991
• An alternatively processed mRNA generated from human hepatocyte growth factor gene
  European Journal of Biochemistry, 1991